Determinants of activity of the HIV-1 maturation inhibitor PA-457

Virology

Volumn 356, Issue 1-2, 2006, Pages 217-224

  Li, Feng ^a   Zoumplis, Dorian ^a   Matallana, Claudia ^a   Kilgore, Nicole R ^a   Reddick, Mary ^a   Yunus, Abdul S ^a   Adamson, Catherine S ^b   Salzwedel, Karl ^a   Martin, David E ^a   Allaway, Graham P ^a   Freed, Eric O ^b   Wild, Carl T ^a  

^a Panacos Pharmaceuticals   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

CA SP1 cleavage; HIV; Maturation inhibitor; PA 457; Viral determinants

Indexed keywords

3 O (3,3 DIMETHYLSUCCINYL)BETULIC ACID; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DRUG ACTIVITY; FEMALE; GENE DELETION; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LEUKEMIA CELL LINE; NONHUMAN; PRIORITY JOURNAL; TERMINAL SEQUENCE;

AMINO ACID SEQUENCE; ANTI-HIV AGENTS; CAPSID PROTEINS; GENE PRODUCTS, GAG; HIV-1; HUMANS; JURKAT CELLS; MICROBIAL SENSITIVITY TESTS; POINT MUTATION; PROTEIN PRECURSORS; SUCCINATES; TRITERPENES; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1; MIRIDAE;

EID: 33750990206     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.07.023     Document Type: Article

References (41)

1. Accola M.A., Hoglund S., and Gottlinger H.G. A putative α-helical structure which overlaps the capsid-p2 boundary in the human immunodeficiency virus type 1 Gag precursor is crucial for viral particle assembly. J. Virol. 72 (1998) 2072-2078
2. Demirov D.G., Ono A., Orenstein J.M., and Freed E.O. Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 955-960
3. Demirov D.G., Orenstein J.M., and Freed E.O. The late domain of human immunodeficiency virus type 1 p6 promotes virus release in a cell type-dependent manner. J. Virol. 76 (2002) 105-117
4. Dorfman T., Bukovsky A., Ohagen A., Hoglund S., and Göttlinger H.G. Functional domains of the capsid protein of human immunodeficiency virus type 1. J. Virol. 68 (1994) 8180-8187
5. Erickson-Viitanen S., Manfredi J., Viitanen P., Tribe D.E., Tritch R., Hutchison C.A., Loeb D.D., and Swanstrom R. Cleavage of HIV-1 gag polyprotein synthesized in vitro: sequential cleavage by the viral protease. AIDS Res. Hum. Retrovir. 5 (1989) 577-591
6. Freed E.O. HIV-1 Gag proteins: diverse functions in the virus life cycle. Virology 251 (1998) 1-15
7. Garrus J.E., von Schwedler U.K., Pornillos O.W., Morham S.G., Zavitz K.H., Wang H.E., Wettstein D.A., Stray K.M., Cote M., Rich R.L., Myszka D.G., and Sundquist W.I. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 107 (2001) 55-65
8. Gottlinger H.G., Dorfman T., Sodroski J.G., and Haseltine W.A. Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 3195-3199
9. Ho S.N., Hunt H.D., Horton R.M., Pullen J.K., and Pease L.R. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77 (1989) 51-59
10. Huang M., Orenstein J.M., Martin M.A., and Freed E.O. p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease. J. Virol. 69 (1995) 6810-6818
11. Kaplan A.H., Zack J.A., Knigge M., Paul D.A., Kempf D.J., Norbeck D.W., and Swanstrom R. Partial inhibition of the human immunodeficiency virus type 1 protease results in aberrant virus assembly and the formation of noninfectious particles. J. Virol. 67 (1993) 4050-4055
12. Kräusslich H.G., Schneider H., Zybarth G., Carter C.A., and Wimmer E. Processing of in vitro-synthesized Gag precursor proteins of human immunodeficiency virus (HIV) type 1 by HIV proteinase generated in Escherichia coli. J. Virol. 62 (1988) 4393-4397
13. Krausslich H.G., Facke M., Heuser A.M., Konvalinka J., and Zentgraf H. The spacer peptide between human immunodeficiency virus capsid and nucleocapsid proteins is essential for ordered assembly and viral infectivity. J. Virol. 69 (1995) 3407-3419
14. Kuiken, C.L., Foley, B., Hahn, B.H., Marx, P.A., McCutchan, F., Mellors, J.W., Mullins, J.I., Wolinksy, S., Korber, B., 2000. HIV sequence compendium 2000. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory.
15. Li F., Goila-Gaur R., Salzwedel K., Kilgore N.R., Reddick M., Matallana C., Castillo A., Zoumplis D., Martin D.E., Orenstein J.M., Allaway G.P., Freed E.O., and Wild C.T. PA-457: a potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 13555-13560
16. Liang C., Rong L., Laughrea M., Kleiman L., and Wainberg M.A. Compensatory point mutations in the human immunodeficiency virus type 1 Gag region that are distal from deletion mutations in the dimerization initiation site can restore viral replication. J. Virol. 72 (1998) 6629-6636
17. Liang C., Rong L., Quan Y., Laughrea M., Kleiman L., and Wainberg M.A. Mutations within four distinct gag proteins are required to restore replication of human immunodeficiency virus type 1 after deletion mutagenesis within the dimerization initiation site. J. Virol. 73 (1999) 7014-7020
18. Liang C., Hu J., Russell R.S., Roldan A., Kleiman L., and Wainberg M.A. Characterization of a putative {alpha}-Helix across the capsid-SP1 boundary that is critical for the multimerization of human immunodeficiency virus type 1 Gag. J. Virol. 76 (2002) 11729-11737
19. Martin-Serrano J., Zang T., and Bieniasz P.D. HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress. Nat. Med. 7 (2001) 1313-1319
20. Mervis R.J., Ahmad N., Lillehoj E.P., Raum M.G., Salazar F.H., Chan H.W., and Venkatesan S. The gag gene products of human immunodeficiency virus type 1: alignment within the gag open reading frame, identification of posttranslational modifications, and evidence for alternative gag precursors. J. Virol. 62 (1988) 3993-4002
21. Morellet N., Druillennec S., Lenoir C., Bouaziz S., and Roques B.P. Helical structure determined by NMR of the HIV-1 (345-392) Gag sequence, surrounding p2: implications for particle assembly and RNA packaging. Protein Sci. 14 (2005) 375-386
22. Morita E., and Sundquist W.I. Retrovirus budding. Annu. Rev. Cell Dev. Biol. 20 (2004) 395-425
23. Nelle T.D., and Wills J.W. A large region within the Rous sarcoma virus matrix protein is dispensable for budding and infectivity. J. Virol. 70 (1996) 2269-2276
24. Ott D.E., Coren L.V., and Gagliardi T.D. Redundant roles for nucleocapsid and matrix RNA-binding sequences in human immunodeficiency virus type 1 assembly. J. Virol. 79 (2005) 13839-13847
25. Parent L.J., Bennett R.P., Craven R.C., Nelle T.D., Krishna N.K., Bowzard J.B., Wilson C.B., Puffer B.A., Montelaro R.C., and Wills J.W. Positionally independent and exchangeable late budding functions of the Rous Sarcoma Virus and Human Immunodeficiency Virus gag proteins. J. Virol. 69 (1995) 5455-5460
26. Pettit S.C., Moody M.D., Wehbie R.S., Kaplan A.H., Nantermet P.V., Klein C.A., and Swanstrom R. The p2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions. J. Virol. 68 (1994) 8017-8027
27. Pettit S.C., Henderson G.J., Schiffer C.A., and Swanstrom R. Replacement of the P1 amino acid of human immunodeficiency virus type 1 Gag processing sites can inhibit or enhance the rate of cleavage by the viral protease. J. Virol. 76 (2002) 10226-10233
28. Puffer B.A., Parent L.J., Wills J.W., and Montelaro R.C. Equine infectious anemia virus utilizes a YXXL motif within the late assembly domain of the Gag p9 protein. J. Virol. 71 (1997) 6541-6546
29. Reil H., Bukovsky A.A., Gelderblom H.R., and Göttlinger H.G. Efficient HIV-1 replication can occur in the absence of the viral matrix protein. EMBO J. 17 (1998) 2699-2708
30. Sakalian M., McMurtrey C.P., Deeg F.J., Maloy C.W., Li F., Wild C.T., and Salzwedel K. 3-O-(3′,3′-dimethysuccinyl) betulinic acid inhibits maturation of the human immunodeficiency virus type 1 Gag precursor assembled in vitro. J. Virol. 80 (2006) 5716-5722
31. Sambrook J., Fritsch E.F., and Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd ed. (1989), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
32. Srinivasakumar N., Hammarskjold M.L., and Rekosh D. Characterization of deletion mutations in the capsid region of human immunodeficiency virus type 1 that affect particle formation and Gag-Pol precursor incorporation. J. Virol. 69 (1995) 6106-6114
33. Swanstrom R., and Wills J.W. Synthesis, assembly, and processing of viral proteins. In: Coffin J.M., Hughes S.H., and Varmus H.E. (Eds). Retroviruses (1997), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY 263-334
34. VerPlank L., Bouamr F., LaGrassa T.J., Agresta B., Kikonyogo A., Leis J., and Carter C.A. Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55Gag. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 7724-7729
35. Wiegers K., Rutter G., Kottler H., Tessmer U., Hohenberg H., and Krausslich H.G. Sequential steps in human immunodeficiency virus particle maturation revealed by alterations of individual Gag polyprotein cleavage sites. J. Virol. 72 (1998) 2846-2854
36. Xiang Y., Cameron C.E., Wills J.W., and Leis J. Fine mapping and characterization of the Rous sarcoma virus Pr76 gag late assembly domain. J. Virol. 70 (1996) 5695-5700
37. Yuan B., Li X., and Goff S.P. Mutations altering the moloney murine leukemia virus p12 gag protein affect virion production and early events of the virus life cycle. EMBO J. 18 (1999) 4700-4710
38. Yuan B., Campbell S., Bacharach E., Rein A., and Goff S.P. Infectivity of Moloney murine leukemia virus defective in late assembly events is restored by late assembly domains of other retroviruses. J. Virol. 74 (2000) 7250-7260
39. Zhou J., Chen C.H., and Aiken C. The sequence of the CA-SP1 junction accounts for the differential sensitivity of HIV-1 and SIV to the small molecule maturation inhibitor 3-O-{3′,3′-dimethylsuccinyl}-betulinic acid. Retrovirology 1 (2004) 1-10
40. Zhou J., Yuan X., Dismuke D., Forshey B.M., Lundquist C., Lee K.H., Aiken C., and Chen C.H. Small-molecule inhibition of human immunodeficiency virus type 1 replication by specific targeting of the final step of virion maturation. J. Virol. 78 (2004) 922-929
41. Zhou J., Huang L., Hachey D.L., Chen C.H., and Aiken C. Inhibition of HIV-1 maturation via drug association with the viral Gag protein in immature HIV-1 particles. J. Biol. Chem.. 280 (2005) 42149-42155